share_log

Stoke Therapeutics(STOK.US) 10% Shareholder Sells US$23 Million in Common Stock

Moomoo News ·  Dec 28, 2024 06:19

$Stoke Therapeutics (STOK.US)$ 10% Shareholder Skorpios Trust sold 2 million shares of common stock on Dec 23, 2024 at an average price of $11.5 for a total value of $23 million.

This transaction involves other related parties: Blue Horizon Enterprise Ltd, Ezbon International Ltd and Montrago Trustees Ltd.

1735337985660265932.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment